MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts. This episode of our regular podcast Voices of Biotech  brings you an in-depth conversation with Jeffrey Whitford, vice president of sustainability and social business innovation at MilliporeSigma, the life sciences division of Merck KGaA. Whitford speaks about the company’s interim and long-term sustainability initiatives and provides a detailed outline of...

Samsung Biologics' James Choi discusses the CDMO’s role in teaming up with Big Pharma to tackle sustainability in the biotech space.    This episode of the Voices of Biotech – brought to you by the BioProcess Insider Expression Platform – brings you an interesting conversation with Choi about the commitment to a “greener” supply chain.   In July 2023, CEOs from Roche, GlaxoSmithKline (GSK), AstraZeneca, Novo Nordisk, Merck KGaA, Sanofi, and contract development manufacturing organization...

The director of strategy and alliance management at Core Biogenesis discusses the advantages, challenges, and how plant-based processes contribute to sustainability in the biotech space.    This episode of the Voices of Biotech – brought to you by the BioProcess Insider Expression Platform – brings you an exciting conversation with Quentin Vicard, strategy and alliance management at Core Biogenesis.   In July 2022, Core Biogenesis bagged $10.5 million in a Series A funding round to build a...

Joel Eichmann, the co-founder and managing director of Green Elephant Biotech, discusses sustainable single-use products, the importance of data, and how healthy people need a healthy planet Eichmann speaks about the firm’s plant-based plastic single-use products and how it is contributing to making the world that little bit greener, despite being told a few years ago the company was ahead of its time. Additionally, the life cycle of the product is discussed, and the conversation evolves to...

The co-CEO’s of the FemTech Association Asia discuss democratizing women’s health and the femtech investment opportunities in Asia.    Davis said their goal is to, “provide a voice for [Asia] and help amplify the industry […]  Femtech is known for being delivered for a premium audience and we want to take this wider and make sure we have solutions that are available, accessible, and affordable for all women.” In addition to increasing accessibility to healthcare for all women, the association...

The three founders of the CGT Circle discuss the importance of decentralized networking for women and why the network was created. In the latest episode of Voices of Biotech, brought to you by the BioProcess Insider Expression Platform, editor of BioProcess Insider Mille Nelson sits down with the three founding members of the CGT Circle. They discuss the demand for local community led networking, leading them to launch their platform which aims to create “decentralized networking” for women...

Episode 5 of Voices of Biotech has launched! This month’s episode of Informa Connect’s latest podcast, brought to you by the BioProcess Insider Expression Platform, features Lara Silverman who sheds some light on career paths, mentorship, and taking ownership of your own development.   Hear Lara discuss DE&I in the cell and gene therapy space, emphasising the goal to get to a place where diversity is naturally embedded into company culture without the need for continuous conversation. She...

When it comes to hiring, there is not enough diversity at upper leadership levels says Bristol Myers Squibb’s Executive Director. In the next episode of Voices of Biotech, brought to you by BioProcess Insider Expression Platform, Vibha Jawa, Executive Director of Bristol Myers Squibb discusses the limited diversity of the hiring pool, building a network of female professionals, and career mentorship. Jawa shares her career journey and the challenges in transitioning from academia to industry....

This episode of the Voices of Biotech - brought to you by the BioProcess Insider Expression Platform -brings you an in-depth conversation with Antoinette Gawin, CEO of Terumo Blood and Cell Technologies. Gawin shares her personal experience of growing up within an immigrant farming community before entering the pharma space and climbing the career ladder. She talks about how people should not be afraid to show vulnerability in the workplace. Additionally, she discusses the importance of...

“Women and people of diverse backgrounds remain underrepresented in the upper echelons of the biopharma c-suite,” says Ilona Gutcher, director of BD&L Oncology at Bayer. Aligning with International Women’s Day (Wednesday 8th March) the BioProcess Insider Expression Platform has released its second episode of Voices of Biotech. “I wouldn’t be here without the I&D Xcelerate program,” says Gutcher, another graduate of the Bayer program launched by Marianne De backer two years ago to...

With the celebration of International Day of Women and Girls in Science on 11th February 2023, we are excited to announce Informa’s latest podcast series produced on the BioProcess Insider Expression Platform (BIEP), where we dive into the complex journey of key female leaders shaping the life science industry. Despite the progress over the last decade, gender parity remains a global issue throughout all levels within the science, technology, engineering, and mathematics (STEM) disciplines....

This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Jason Foster, CEO of Ori Biotech. The company experienced a year of transition in 2022 with the closing of its $100 million Series B funding round and the expansion of its paperless cell and gene therapy (CGT) platform.  Foster speaks about the current process of taking the platform from clinical to commercial through feedback derived from its LightSpeed Early Access Program...

The latest edition of the BioProcess Insider Expression Platform has NIBRT’s Killian O'Driscoll speaking on Ireland’s robust biomanufacturing environment, training programs, and vendor-led technologies. Ireland has long established itself as a drug manufacturing hub and is home to commercial production sites run by Big Pharma firms including Pfizer, J&J, Eli Lilly, and AstraZeneca, as well as numerous third-party manufacturing organizations and bioprocess vendor firms. The business...

Bikash Chatterjee and Stephanie Gaulding, CEO and MD at drug development consultancy firm Pharmatech Associates, talk about the different partnering and outsourcing strategies innovators can take, with a specific focus on smaller and mid-sized biotechs, which often don’t have the same level of in-built CMC expertise as Big Pharma. Whether you go with a single end-to-end CDMO or a multi-model approach, one thing is clear: know your product, know your needs and plan early. This conversation...

This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Stuart Curbishley, head of business and project development, advanced therapies at University of Birmingham and Ivan Wall, CEO, Four-Plus and director of the National Training Center for advanced therapies manufacturing.   We delve deep into the challenges concerning training talent in the advanced therapy and wider biopharma space, potential solutions that could filter the...

Another interview taken from the BioProcess International Theater at BIO, in June 2022. This time, I sat down with Brian Finrow, the Co-Founder and CEO of Lumen Biosciences - a biotech looking to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. The firm is developing ‘oral antibodies’ using its platform based on spirulina – the protein-rich cyanobacteria touted by many health enthusiasts as a ‘superfood’ – to create tiny...

Emmanuel Ligner, CEO of self-described bioprocess critical actor Cytiva, talks us through the changing biomanufacturing landscape and unveils his firm’s sustainability report during a fireside chat at the BioProcess International Theater at BIO in June

In the first of my series of interviews from BIO 2022 in San Diego, I speak with Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, one of the most prominent contract development and manufacturing organizations (CDMOs). He talks about the CDMO's part in battling COVID-19, the major capital expenditure projects underway at facilities in Denmark, North Carolina, and elsewhere, and Fujifilm's presence in the advanced therapies space, and why it has chosen to invest in mRNA, gene...

There is no lack of talented women in the biotech space but the gates blocking their progression must be open for them to fully realize their potential. “Career development is an integral part of DEI because it’s diversity inclusion at the starting gate,” rather than just a tick-box exercise among the C-suite, said Nadine Ritter, president and analytical advisor at Global Biotech Experts at a DEI coffee morning at BPI Europe in Vienna. “It will never really change at the top unless we...

Over the past decade, the relationships drug developers have with their third-party biomanufacturers has evolved from relatively simple transactional services to integrated and complex strategic partnerships. This podcast replays a panel discussion from EBD's BIO EUROPE Spring event where editor Dan Stanton discusses the changing way pharma works with CDMOs with delegates from Samsung Biologics, Catalent, and AGC Biologics. Topics covered include: The history of CDMOs, M&A within the...

Dendreon, a pioneer in the cell therapy space through its commercial product Provenge, has relaunched itself as a contract development and manufacturing organization (CDMO). BioProcess Insider speaks with Maria Cho, the VP of Business Development and Corporate Strategy, about Dendreon's strategic growth efforts in the cellular immunotherapy space and how it is embracing its proven success in the field to support others.

A digital twin is a virtual representation that serves as the real-time digital counterpart of a physical object or process. Biopharma giant GlaxoSmithKline (GSK) has adopted this technology to advance its vaccine development and manufacturing division. A year after partnering with Siemens and Atos to pilot a digital twin in order to create a real-time simulation of the entire vaccine manufacturing process, we sat down (virtually, sadly) with Matt Harrison, head of Sciences, Digital...

Having raised $82 million in its latest funding round, tech firm Cellares Corporation is looking to advance development of its cell therapy manufacturing platform, the Cell Shuttle.   We spoke with co-founder and CEO Fabian Gerlinghaus about the current limitations in CAR-T production and how the Cell Shuttles’ scalable, modular, and automated nature could be a gamechanger in the burgeoning space   Keep up with BioProcess Insider on our website. Follow us on LinkedIn and...

Ernst & Young’s Adlai Goldberg describes the steps industry must take to advance the advanced therapy space and how it must move to balance the individualized autologous approach with more sustainable allogeneic products.